Murchinson Ltd. 180 Life Sciences Corp. Transaction History

Murchinson Ltd.

  • $342 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$5.11 - $10.81 $486,860 - $1.03 Million
-95,276 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$6.7 - $11.98 $638,349 - $1.14 Million
95,276 New
95,276 $953,000

About 180 Life Sciences Corp.

ATNF Quotes by TradingView
  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $81.1M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track Murchinson Ltd. Portfolio

Follow Murchinson Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Murchinson Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Murchinson Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email